Methylation Significance and Neurodegenerative Markers in Parkinson Condition [General Clinical Chemistry] <<>>

Written by Obeid, R., Schadt, A., Dillmann, U., Kostopoulos, P., Fassbender, K., Herrmann, W. on September 29, 2009 – 12:00 am -

Background: Increased concentrations of plasma outright homocysteine (tHcy) father been associated with age-related diseases, including dementia, stroke, and Parkinson malady (PD). Methylation standing energy constituent Hcy metabolism to neurodegenerative proteins in patients with PD.

Methods: We tested blood samples from 87 patients with PD (median age 68 years; 35 men) for tHcy, methylmalonic acid (MMA), vitamin B12, vitamin B6, folate, S-adenosyl methionine (SAM), S-adenosyl homocysteine (SAH), and amyloid-β(1–42). We sedate citrate blood from a subset of 45 patients to get platelet-rich plasma, and we cast-off washed platelets to build room extracts for amyloid herald protein (APP) and -synuclein assays. We worn perception parenchyma sonography to guess the substantia nigra echogenic square in a subset of 59 patients.

Results: Serum concentrations of THcy were increased in PD patients (median 14.8 µmol/L). THcy (β coefficient = –0.276) and serum creatinine (β = –0.422) were expressive predictors of the proportion of SAM/SAH in plasma (P < 0.01). The plasma SAM/SAH correlation was a eloquent determinant for DemTect scores (β = 0.612, P = 0.004). Relevant adversarial correlations were base middleman concentrations of SAH in plasma and platelet APP and liaison SAM and platelet -synuclein. A larger echogenic range of the substantia nigra was kin to higher serum concentrations of MMA (P = 0.016).

Conclusions: Markers of neurodegeneration (APP, -synuclein) are interconnected to markers of methylation (SAM, SAH) in patients with PD. Best cognitive ritual was coupled to higher methylation latent (SAM/SAH ratio).

<<>>

Tags: ,
Posted in Clinical Chemistry |

Comments are closed.